JP2004526705A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526705A5
JP2004526705A5 JP2002563772A JP2002563772A JP2004526705A5 JP 2004526705 A5 JP2004526705 A5 JP 2004526705A5 JP 2002563772 A JP2002563772 A JP 2002563772A JP 2002563772 A JP2002563772 A JP 2002563772A JP 2004526705 A5 JP2004526705 A5 JP 2004526705A5
Authority
JP
Japan
Prior art keywords
blood vessel
blood
substance
catheter
glcnac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002563772A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526705A (ja
JP5303088B2 (ja
Filing date
Publication date
Priority claimed from US09/781,182 external-priority patent/US7041657B2/en
Application filed filed Critical
Publication of JP2004526705A publication Critical patent/JP2004526705A/ja
Publication of JP2004526705A5 publication Critical patent/JP2004526705A5/ja
Application granted granted Critical
Publication of JP5303088B2 publication Critical patent/JP5303088B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002563772A 2001-02-12 2002-02-08 血管構造及び／または機能のモジュレーションのための組成物及び方法 Expired - Lifetime JP5303088B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/781,182 US7041657B2 (en) 2001-02-12 2001-02-12 Compositions and methods for modulation of vascular structure and/or function
US09/781,182 2001-02-12
PCT/US2002/003792 WO2002063961A1 (en) 2001-02-12 2002-02-08 Composition and methods for modulation of vascular structure and/or function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010151827A Division JP5543861B2 (ja) 2001-02-12 2010-07-02 血管構造及び／または機能のモジュレーションのための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2004526705A JP2004526705A (ja) 2004-09-02
JP2004526705A5 true JP2004526705A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2011-09-01
JP5303088B2 JP5303088B2 (ja) 2013-10-02

Family

ID=25121948

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2002563772A Expired - Lifetime JP5303088B2 (ja) 2001-02-12 2002-02-08 血管構造及び／または機能のモジュレーションのための組成物及び方法
JP2010151827A Expired - Lifetime JP5543861B2 (ja) 2001-02-12 2010-07-02 血管構造及び／または機能のモジュレーションのための組成物及び方法
JP2014060330A Expired - Lifetime JP5945293B2 (ja) 2001-02-12 2014-03-24 血管構造及び／または機能のモジュレーションのための組成物及び方法
JP2015218394A Pending JP2016053067A (ja) 2001-02-12 2015-11-06 血管構造及び／または機能のモジュレーションのための組成物及び方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2010151827A Expired - Lifetime JP5543861B2 (ja) 2001-02-12 2010-07-02 血管構造及び／または機能のモジュレーションのための組成物及び方法
JP2014060330A Expired - Lifetime JP5945293B2 (ja) 2001-02-12 2014-03-24 血管構造及び／または機能のモジュレーションのための組成物及び方法
JP2015218394A Pending JP2016053067A (ja) 2001-02-12 2015-11-06 血管構造及び／または機能のモジュレーションのための組成物及び方法

Country Status (11)

Country Link
US (7) US7041657B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP1365651B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (4) JP5303088B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (3) AU2002306455B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2437812C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK1365651T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES2456695T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL157327A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA03007176A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ527872A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2002063961A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US7041657B2 (en) 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
CA2511807A1 (en) * 2002-12-31 2004-07-22 Marine Polymer Technologies, Inc. Hemostatic compositions and uses therefor
JP5028086B2 (ja) 2003-02-24 2012-09-19 マリン ポリマー テクノロジーズ，インコーポレーテッド 細胞−ポリマー繊維組成物及びその使用
US8613772B2 (en) * 2003-04-21 2013-12-24 Rsb Spine Llc Lateral mount implant device
NZ546204A (en) * 2003-09-12 2009-12-24 Marinepolymer Tech Inc Vascular access preservation in haemodialysis patients
US7803182B2 (en) * 2004-05-28 2010-09-28 Cordis Corporation Biodegradable vascular device with buffering agent
US7785615B2 (en) * 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
US20070031468A1 (en) * 2005-08-04 2007-02-08 Endomedix, Inc. Modified chitosan for vascular embolization
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US20070243130A1 (en) * 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US20090010982A1 (en) * 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
US7854923B2 (en) 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
ES2552842T3 (es) 2007-02-19 2015-12-02 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
NZ582330A (en) 2007-06-27 2012-05-25 Marinepolymer Tech Inc COMPLEXES OF IL-15 AND IL-15Ra (RECEPTOR ALPHA) AND USES THEREOF
US8486033B2 (en) * 2007-07-18 2013-07-16 Marine Polymer Technologies, Inc. Application of polymeric materials to screens to facilitate hemostasis and wound healing
US11253399B2 (en) 2007-12-06 2022-02-22 Smith & Nephew Plc Wound filling apparatuses and methods
US20130096518A1 (en) 2007-12-06 2013-04-18 Smith & Nephew Plc Wound filling apparatuses and methods
WO2010034019A1 (en) 2008-09-22 2010-03-25 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
WO2010065922A2 (en) * 2008-12-04 2010-06-10 Biochemics, Inc. Methods and compositions for tattoo removal
EP2498820B1 (en) 2009-11-13 2019-01-09 University of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
CN107412772A (zh) 2010-04-15 2017-12-01 海洋聚合物技术公司 聚‑n‑乙酰葡萄糖胺纳米纤维的抗菌应用
NZ732118A (en) 2011-04-15 2018-11-30 Marine Polymer Tech Inc Treatment of disease with poly-n-acetylglucosamine nanofibers
US9616088B2 (en) 2013-03-13 2017-04-11 Gel-E, Inc. Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
MX2015011418A (es) 2013-03-14 2015-12-16 Marinepolymer Tech Inc Tratamiento de enfermedades con nanofibras de poli-n-acetilglucosamina.
EP4403194A3 (en) 2018-11-19 2024-10-16 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US585559A (en) * 1897-06-29 Piano-hammer
US3232836A (en) 1959-08-24 1966-02-01 Pfizer & Co C Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine
US3632754A (en) 1968-02-12 1972-01-04 Lescarden Ltd Use of chitin for promoting wound healing
US3903268A (en) 1968-02-12 1975-09-02 Lescarden Ltd Chitin and chitin derivatives for promoting wound healing
US3911116A (en) 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3989535A (en) * 1974-02-11 1976-11-02 American Cyanamid Company Solution of poly(N-acetyl-D-glucosamine)
US4394373A (en) 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
JPS61240963A (ja) 1985-04-18 1986-10-27 ユニチカ株式会社 創傷被覆保護材
JPH0813746B2 (ja) * 1987-02-27 1996-02-14 ユニチカ株式会社 止血剤
CA2004802A1 (en) 1988-12-07 1990-06-07 Christopher R. Bentley Formulations for treating slow and non-healing wounds
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
CA2059380A1 (en) 1991-01-24 1992-07-25 Yiu-Kuen T. Lam Endothelin receptor antagonists isolated from microbispora
US5219749A (en) 1991-10-09 1993-06-15 Institute For Molecular Biology & Biotechnology/Forth Process for isolating and preparing purified chitin deacetylase
US5443481A (en) 1992-07-27 1995-08-22 Lee; Benjamin I. Methods and device for percutaneous sealing of arterial puncture sites
GB9305464D0 (en) * 1993-03-17 1993-05-05 Logax Limited Document file
JPH09504719A (ja) 1993-11-03 1997-05-13 クラリオン、ファーマシューティカルズ、インコーポレイテッド 止血パッチ
US5437292A (en) 1993-11-19 1995-08-01 Bioseal, Llc Method for sealing blood vessel puncture sites
US5635493A (en) * 1993-12-01 1997-06-03 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics
US6063911A (en) 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US6743783B1 (en) 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5846952A (en) 1993-12-01 1998-12-08 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
US5858350A (en) 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5622834A (en) 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
US5624679A (en) 1993-12-01 1997-04-29 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers
US5686115A (en) 1993-12-01 1997-11-11 Marine Polymer Technologies, Inc. Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
EP0748215B1 (en) 1994-02-17 2003-05-28 New York Blood Center, Inc. Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
WO1995032671A1 (en) 1994-06-01 1995-12-07 Perclose, Inc. Method and device for providing vascular hemostasis
JPH0853368A (ja) * 1994-08-09 1996-02-27 Kyoto Yakuhin Kogyo Kk 軟膏製剤
US5814066A (en) 1994-12-23 1998-09-29 The University Of Virginia Patent Foundation Reduction of femoral arterial bleeding post catheterization using percutaneous application of fibrin sealant
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
WO1996023523A1 (en) 1995-02-03 1996-08-08 Korea Institute Of Science And Technology Novel hemostatic composition
AU5917896A (en) 1995-06-06 1996-12-24 Marine Polymer Technologies, Inc. Poly-beta-1-4-N-acetylglucosamine
JPH09169653A (ja) * 1995-12-22 1997-06-30 Unitika Ltd キチン止血剤
JPH09169654A (ja) * 1995-12-22 1997-06-30 Unitika Ltd 止血剤
US5728132A (en) 1996-04-08 1998-03-17 Tricardia, L.L.C. Self-sealing vascular access device
JPH09291036A (ja) * 1996-04-26 1997-11-11 San Five Kk 粉末状キチン質創傷治療剤
JPH09328432A (ja) * 1996-06-06 1997-12-22 Unitika Ltd スプレー剤
JPH1075998A (ja) * 1996-09-05 1998-03-24 Unitika Ltd 綿状創傷保護材
US5855559A (en) 1997-02-14 1999-01-05 Tricardia, Inc. Hemostatic agent delivery device having built-in pressure sensor
US6193670B1 (en) 1997-02-14 2001-02-27 Tricardia, Llc Hemostatic agent delivery device having built-in pressure sensor
JPH10295699A (ja) * 1997-04-24 1998-11-10 Clinical Supply:Kk 止血用具
US6033427A (en) 1998-01-07 2000-03-07 Lee; Benjamin I. Method and device for percutaneous sealing of internal puncture sites
US6056970A (en) 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6613070B2 (en) 1998-08-04 2003-09-02 Baxter International Inc. System and method for sealing vascular penetrations with hemostatic gels
US6334865B1 (en) 1998-08-04 2002-01-01 Fusion Medical Technologies, Inc. Percutaneous tissue track closure assembly and method
US20020197302A1 (en) 1998-11-12 2002-12-26 Cochrum Kent C. Hemostatic polymer useful for rapid blood coagulation and hemostasis
US6361551B1 (en) 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
JP4159682B2 (ja) * 1998-12-22 2008-10-01 株式会社クラレ 止血材
US7041657B2 (en) 2001-02-12 2006-05-09 Marine Polymer Technologies Inc. Compositions and methods for modulation of vascular structure and/or function
US6693188B2 (en) 2001-08-08 2004-02-17 Cargill Incorporated N-acetyl-D-glucosamine and process for producing N-acetyl-D-glucosamine
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
CA2511807A1 (en) 2002-12-31 2004-07-22 Marine Polymer Technologies, Inc. Hemostatic compositions and uses therefor
JP5028086B2 (ja) 2003-02-24 2012-09-19 マリン ポリマー テクノロジーズ，インコーポレーテッド 細胞−ポリマー繊維組成物及びその使用
NZ546204A (en) 2003-09-12 2009-12-24 Marinepolymer Tech Inc Vascular access preservation in haemodialysis patients
ES2552842T3 (es) 2007-02-19 2015-12-02 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos

Similar Documents

Publication Publication Date Title
JP2004526705A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US11033280B2 (en) Tissue compression device with fixation and tension straps
WO2002096502A3 (en) Ultrasound-based occlusive procedure for medical treatment
Dykewicz et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
WO2004028602A3 (en) Single-use syringe
WO2004012601A3 (en) Apparatus for sealing punctures in blood vessels
WO2007044833A3 (en) Apparatus and methods for endometrial biopsies
EP4585168A3 (en) A device for treatment of aneurysm
WO2009006482A9 (en) Vascular closure devices and methods providing hemostatic enhancement
WO2002078549A3 (en) Method and apparatus for the detection and ligation of uterine arteries
AU2003294289A1 (en) Method and apparatus for the detection and occlusion of blood vessels
WO2005030295A3 (en) Insertable ultrasound probes, systems, and methods for thermal therapy
WO2003069332A3 (en) Detection and/or monitoring of synuclein-related diseases
IL148795A0 (en) Apparatus and method for monitoring tissue vitality parameters for the diagnosis of body metabolic emergency state
WO2007092419A3 (en) Method for non-invasive detection and treatment of cerebral aneurysms
JP6144683B2 (ja) 開いた血管を閉鎖するための閉鎖デバイス
CN103519830B (zh) 一种有创动脉血压监测时的采血装置
CA2362424A1 (en) Bloodless treating device
WO2005067577A3 (en) Devices and methods for blood flow assistance
CN211560318U (zh) 一种弹性加压固定克氏针
DE60234698D1 (de) Resorbierbare, medizinische Vorrichtung zur chirurgischen Abdichtung
WO2010014413A3 (en) Lead delivery device and method
EP2236108A3 (en) Inflatable blanket for use in cardiac surgery
WO2007117589A3 (en) Enhanced fc receptor-mediated tumor necrosis factor superfamily and chemokine mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
ATE383116T1 (de) Endovaskuläre chirurgische vorrichtung